Prevalence and associated factors of silent brain infarcts in a mediterranean cohort of hypertensives

Hypertension

Volumn 64, Issue 3, 2014, Pages 658-663

  Delgado, Pilar ^a   Riba Llena, Iolanda ^a   Tovar, José L ^c   Jarca, Carmen I ^d   Mundet, Xavier ^b   López Rueda, Antonio ^a   Orfila, Francesc ^b   Llussà, Judit ^b,e   Manresa, Josep M ^b,f   Álvarez Sabín, José ^c   Nafría, Cristina ^a   Fernández, José L ^g   Maisterra, Olga ^c   Montaner, Joan ^a,c  

^a VALL D'HEBRON INSTITUTE OF ONCOLOGY   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Hospital de la Vall Hebron   (Spain)

^d Emergency Department   (Spain)

^e INSTITUT CATALÀ DE LA SALUT   (Spain)

^f IDIAP Jordi Gol   (Spain)

^g Neurorradiology Clínica Dr Manchón   (Spain)

Author keywords

Hypertension; Stroke

Indexed keywords

ADULT; AGED; ARTICLE; BASAL GANGLION; BRAIN INFARCTION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COHORT ANALYSIS; DEMENTIA; DISEASE ASSOCIATION; FEMALE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MALE; MICROALBUMINURIA; MIDDLE AGED; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

HYPERTENSION; STROKE;

AGED; ALBUMINURIA; BRAIN INFARCTION; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LONGITUDINAL STUDIES; MALE; MEDITERRANEAN REGION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROIMAGING; PREVALENCE; RISK FACTORS; SEX FACTORS; SPAIN;

EID: 84907313625     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.03563     Document Type: Article

References (39)

1. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: A systematic review. Lancet Neurol. 2007;6:611-619.
2. Kwon HM, Kim BJ, Oh JY, Kim SJ, Lee SH, Oh BH, Yoon BW. Retinopathy as an indicator of silent brain infarction in asymptomatic hypertensive subjects. J Neurol Sci. 2007;252:159-162.
3. Kato T, Inoue T, Yamagishi S, Morooka T, Okimoto T, Node K. Low-density lipoprotein subfractions and the prevalence of silent lacunar infarction in subjects with essential hypertension. Hypertens Res. 2006;29:303-307.
4. Henskens LH, Kroon AA, van Oostenbrugge RJ, Gronenschild EH, Fuss-Lejeune MM, Hofman PA, Lodder J, de Leeuw PW. Increased aortic pulse wave velocity is associated with silent cerebral small-vessel disease in hypertensive patients. Hypertension. 2008;52:1120-1126.
5. Henskens LH, van Oostenbrugge RJ, Kroon AA, Hofman PA, Lodder J, de Leeuw PW. Detection of silent cerebrovascular disease refines risk stratification of hypertensive patients. J Hypertens. 2009;27:846-853.
6. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: A prospective study. Circulation. 2003;107:1401-1406.
7. Kario K, Pickering TG, Hoshide S, Eguchi K, Ishikawa J, Morinari M, Hoshide Y, Shimada K. Morning blood pressure surge and hypertensive cerebrovascular disease: role of the alpha adrenergic sympathetic nervous system. Am J Hypertens. 2004;17:668-675.
8. Kario K, Eguchi K, Hoshide S, Hoshide Y, Umeda Y, Mitsuhashi T, Shimada K. U-curve relationship between orthostatic blood pressure change and silent cerebrovascular disease in elderly hypertensives: orthostatic hypertension as a new cardiovascular risk factor. J Am Coll Cardiol. 2002;40:133-141.
9. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension. 2001;38:852-857.
10. Kario K, Shimada K, Schwartz JE, Matsuo T, Hoshide S, Pickering TG. Silent and clinically overt stroke in older Japanese subjects with whitecoat and sustained hypertension. J Am Coll Cardiol. 2001;38:238-245.
11. Kario K, Matsuo T, Kobayashi H, Hoshide S, Shimada K. Hyperinsulinemia and hemostatic abnormalities are associated with silent lacunar cerebral infarcts in elderly hypertensive subjects. J Am Coll Cardiol. 2001;37:871-877.
12. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension. 1996;27:130-135.
13. Shimizu M, Ishikawa J, Yano Y, Hoshide S, Shimada K, Kario K. The relationship between the morning blood pressure surge and low-grade inflammation on silent cerebral infarct and clinical stroke events. Atherosclerosis. 2011;219:316-321.
14. Ishikawa J, Tamura Y, Hoshide S, Eguchi K, Ishikawa S, Shimada K, Kario K. Low-grade inflammation is a risk factor for clinical stroke events in addition to silent cerebral infarcts in Japanese older hypertensives: The Jichi Medical School ABPM Study, wave 1. Stroke. 2007;38:911-917.
15. Kario K, Ishikawa J, Eguchi K, Morinari M, Hoshide S, Ishikawa S, Shimada K. Sleep pulse pressure and awake mean pressure as independent predictors for stroke in older hypertensive patients. Am J Hypertens. 2004;17(5 Pt 1):439-445.
16. Selvetella G, Notte A, Maffei A, Calistri V, Scamardella V, Frati G, Trimarco B, Colonnese C, Lembo G. Left ventricular hypertrophy is associated with asymptomatic cerebral damage in hypertensive patients. Stroke. 2003;34:1766-1770.
17. Ma JF, Sun JL, Zhao J, Wei X, Wang BS, Fu Y. Relationship between nocturnal blood pressure variation and silent cerebral infarction in Chinese hypertensive patients. J Neurol Sci. 2010;294:67-69.
18. Ishikawa S, Kayaba K, Gotoh T, Nago N, Nakamura Y, Tsutsumi A, Kajii E. Incidence of total stroke, stroke subtypes, and myocardial infarction in the Japanese population: The JMS Cohort Study. J Epidemiol. 2008;18:144-150.
19. vanBoxtel MPJ, Henskens LHG, Kroon AA, Hofman PAM, Gronenschild EHBM, Jolles J, de Leeuw PW. Ambulatory blood pressure, asymptomatic cerebrovascular damage and cognitive function in essential hypertension. J Hum Hypertens. 2006;20:5-13.
20. Marrugat J, Vila J, Baena-Díez JM, Grau M, Sala J, Ramos R, Subirana I, Fitó M, Elosua R. [Relative validity of the 10-year cardiovascular risk estimate in a population cohort of the REGICOR study]. Rev Esp Cardiol. 2011;64:385-394.
21. Sierra C, de La Sierra A, Mercader J, Gómez-Angelats E, Urbano-Márquez A, Coca A. Silent cerebral white matter lesions in middle-aged essential hypertensive patients. J Hypertens. 2002;20:519-524.
22. Zhu YC, Dufouil C, Tzourio C, Chabriat H. Silent brain infarcts: A review of MRI diagnostic criteria. Stroke. 2011;42:1140-1145.
23. Wardlaw JM, Smith EE, Biessels GJ, et al; STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822-838.
24. Riba-Llena I, Jarca CI, Mundet X, Tovar JL, Orfila F, López-Rueda A, Nafría C, Fernández JL, Castañé X, Domingo M, Alvarez-Sabín J, Fernández-Cortiñas I, Maisterra O, Montaner J, Delgado P. Investigating silent strokes in hypertensives: A magnetic resonance imaging study (ISSYS): rationale and protocol design. BMC Neurol. 2013;13:130.
25. Berger K, Hense HW, Rothdach A, Weltermann B, Keil U. A single question about prior stroke versus a stroke questionnaire to assess stroke prevalence in populations. Neuroepidemiology. 2000;19:245-257.
26. American Psychiatric Association. Manual Diagnóstico y Estadístico de los trastornos mentales, DSM-IV-TR. Barcelona: Masson; 2002.
27. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
28. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28:1462-1536.
29. Gosse P, Jan E, Coulon P, Cremer A, Papaioannou G, Yeim S. ECG detection of left ventricular hypertrophy: The simpler, the better? J Hypertens. 2012;30:990-996.
30. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
31. Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke. 2002;33:21-25.
32. Longstreth WT Jr, Bernick C, Manolio TA, Bryan N, Jungreis CA, Price TR. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: The Cardiovascular Health Study. Arch Neurol. 1998;55:1217-1225.
33. Prabhakaran S, Wright CB, Yoshita M, Delapaz R, Brown T, DeCarli C, Sacco RL. Prevalence and determinants of subclinical brain infarction: The Northern Manhattan Study. Neurology. 2008;70:425-430.
34. Bushnell C, McCullough LD, Awad IA, et al; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Council for High Blood Pressure Research. Guidelines for the prevention of stroke in women: A statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2014;45:1545-1588.
35. Vinyoles E, Felip A, Pujol E, de la Sierra A, Durà R, del Rey RH, Sobrino J, Gorostidi M, de la Figuera M, Segura J, Banegas JR, Ruilope LM; Spanish Society of Hypertension ABPM Registry. Clinical characteristics of isolated clinic hypertension. J Hypertens. 2008;26:438-445.
36. Lee M, Saver JL, Chang KH, Liao HW, Chang SC, Ovbiagele B. Impact of microalbuminuria on incident stroke: A meta-analysis. Stroke. 2010;41:2625-2631.
37. Tsioufis C, Dimitriadis K, Andrikou E, Thomopoulos C, Tsiachris D, Stefanadi E, Mihas C, Miliou A, Papademetriou V, Stefanadis C. ADMA, C-reactive protein, and albuminuria in untreated essential hypertension: A cross-sectional study. Am J Kidney Dis. 2010;55:1050-1059.
38. O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension. 2005;46:200-204.
39. Das RR, Seshadri S, Beiser AS, Kelly-Hayes M, Au R, Himali JJ, Kase CS, Benjamin EJ, Polak JF, O'Donnell CJ, Yoshita M, D'Agostino RB Sr, DeCarli C, Wolf PA. Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study. Stroke. 2008;39:2929-2935.